/
AFL
$119.78-$0.37 (-0.31%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$61.2B
509M shares
52-week range
$96.95 – $120.29
98% from low
Sector
ACCIDENT & HEALTH INSURANCE
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$66.12
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.71B | $22.24B | $22.26B | $21.55B | $19.15B | $18.84B | $19.13B | $17.44B |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $12.31B | $10.65B |
| Gross profit | $21.71B | $22.24B | $22.26B | $21.55B | $19.15B | $18.84B | $6.82B | $6.79B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 35.6% | 38.9% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $3.98B | $4.45B | $4.16B | $5.21B | $4.87B | $5.26B | $6.42B | $4.64B |
| EBITDA | $3.98B | $4.45B | $4.16B | $5.21B | $4.87B | $5.26B | $6.42B | $5.53B |
| Net income | $2.92B | $3.30B | $4.78B | $4.23B | $4.42B | $4.66B | $5.44B | $3.65B |
| Net margin | 13.5% | 14.9% | 21.5% | 19.6% | 23.1% | 24.7% | 28.5% | 20.9% |
| EPS (diluted) | 3.77 | 4.43 | 6.67 | 6.39 | 6.93 | 7.78 | 9.63 | 6.83 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $16.8B | $7.07 | $6.98–$7.28 | 9 |
| 2027 | $16.9B | $7.59 | $7.38–$8.36 | 9 |
| 2028 | $17.2B | $7.98 | $7.85–$8.10 | 4 |
| 2029 | $17.4B | $8.20 | $7.88–$8.47 | 2 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$169.95
Price
$119.78
Implied upside
+42%
Peer comparison
Aflac Inc.
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments: Aflac Japan, which generates the maximum revenue, and Aflac U.S.
www.aflac.com- Employees
- 12,716
- IPO / List date
- Aug 27, 1973
- HQ
- COLUMBUS, GA
Held by traders on TradeandTell
No one on the platform currently holds AFL.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 667,700 | $73.3M |
| Bridgewater Associatesas of 2026-03-31 | 61,625 | $6.8M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 1.99% ($2.38/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-20 | $0.6100 | 2026-06-01 |
| 2026-02-18 | $0.6100 | 2026-03-02 |
| 2025-11-19 | $0.5800 | 2025-12-01 |
| 2025-08-20 | $0.5800 | 2025-09-02 |
| 2025-05-21 | $0.5800 | 2025-06-02 |
| 2025-02-19 | $0.5800 | 2025-03-03 |
| 2024-11-20 | $0.5000 | 2024-12-02 |
| 2024-08-21 | $0.5000 | 2024-09-02 |
| 2024-05-21 | $0.5000 | 2024-06-03 |
| 2024-02-20 | $0.5000 | 2024-03-01 |
Recent trades on TradeandTell
No one on the platform has traded AFL yet.
